The NY Times reported that Bristol-Myers-Squibb will soon be paying about $300 million in exchange for the US Department of Justice deferring prosecution of its alleged criminal conduct. The allegations were that the company inflated sales figures that it reported to investors. The company's current CEO, Peter R. Dolan, has acknowledged that the company inflated revenue by about $2.5 billion from 1999 to 2002. (See this Forbes article for more on Dolan's record.)
Artikel Terkait
Princess Health and Another Historic Case of Health Care Mismanagement. PrincessicciaTo toot my own horn a bit, the next in my series of historic cases of health care mismanagement has appeared in our loc- Princess Health and Stryker Subsidiary Pleads Guilty to Selling Adulterated Devices, Former CEO of Subsidiary Pleads Guilty to Fraud, Stryker's Track Record Goes Unremarked. PrincessicciaThe US Thanksgiving Day parade is over, so it must be time for the march of legal settlements to begin again. Our next
- Princess Health and Health Care Professional Societies Whose Leadership Betrays Their Own Members - the APA Alleged to Have Supported Torture, and Deceived its Members to Collect Money. PrincessicciaHealth care professionals usually view their professional societies as allies, supporting their values and acting in th
- Princess Health and The Troubles at Cooper Continue, Lately Gruesomely, But Will Its Leadership and Governance Change This Time? - Part II: the History since 2005. PrincessicciaIn our most recent post, we noted the latest tragic, and gruesome development at Cooper Health System, the largest hosp
- Princess Health and Boston Scientific Settles Case of Defective Stent Systems. PrincessicciaThe Boston Globe reported that Boston Scientific has settled a suit brought by the US Department of Justice that allege
- Princess Health and Bristol-Myers-Squibb Settling Case of Inflated Sales Figures. PrincessicciaThe NY Times reported that Bristol-Myers-Squibb will soon be paying about $300 million in exchange for the US Departmen
Princess Health and Bristol-Myers-Squibb Settling Case of Inflated Sales Figures.Princessiccia
4/
5
Oleh
Gusty
